Allopregnanolone as a Regenerative Treatment for Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:February 20, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Parkinson DiseaseLast Updated:February 20, 2024Recruiting
Condition(s):Tourette Syndrome; Tourette Syndrome in AdolescenceLast Updated:June 9, 2023Completed
Condition(s):Traumatic Brain Injury; Posttraumatic EpilepsyLast Updated:June 28, 2017Completed
Condition(s):Fragile X-associated Tremor/Ataxia SyndromeLast Updated:December 6, 2018Completed
Condition(s):Alzheimer DementiaLast Updated:April 25, 2023Active, not recruiting
Condition(s):Alcohol Use DisorderLast Updated:March 18, 2024Completed
Condition(s):Alzheimer Dementia; Late Onset Alzheimer Disease; Neurodegenerative DiseasesLast Updated:September 1, 2023Recruiting
Condition(s):Mild Cognitive Impairment; Alzheimer DiseaseLast Updated:July 5, 2019Completed
Condition(s):Premenstrual Dysphoric DisorderLast Updated:October 28, 2020Completed
Condition(s):Menstrual MigraineLast Updated:July 26, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.